Stanford University
Showing 71-80 of 170 Results
-
Lou Halamek
Professor of Pediatrics (Neonatology) and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly Interests1. development of hospital operations centers coupled with sophisticated simulation capabilities
2. re-creation of near misses and adverse events
3. optimizing human and system performance during resuscitation
4. optimizing pattern recognition and situational awareness at the bedside
5. evaluation and optimization of debriefing
6. patient simulator design -
Alica Hartmann
Affiliate, Pediatrics - Neonatology
Visiting Postdoctoral Scholar, Pediatrics - NeonatologyBioAlica Hartmann is a postdoctoral researcher at the University Medical Center Mainz, Germany, with a background in public health, ophthalmology, and population-based epidemiology. Her work focuses on early-life risk factors and their long-term health consequences, with a particular interest in preterm birth, fetal growth restriction, and sex-specific differences in health outcomes. During her visiting research stay at Stanford, she will join the Department of Pediatrics to further develop her work in perinatal epidemiology.
-
Susan R. Hintz, M.D., M.S. Epi.
Robert L. Hess Family Professor and Professor, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly Interests1) Early childhood neurodevelopmental outcomes, mortality and morbidities of extremely premature and high-risk infants
2) Use of advanced neuroimaging and other predictors of neurodevelopmental outcomes in high-risk infants, evidence-based interventions to improve outcomes
3) Quality and process improvement throughout the continuum of care
4) Natural history and outcomes of complex fetal anomalies, implementing innovative fetal therapies. -
Anca M. Hrastinski, MD
Assistant Professor of Pediatrics
Current Research and Scholarly InterestsI am a physician-scientist, neonatologist, and stem cell biologist whose research focuses on understanding mechanisms of human brain development, neuroinflammation, and neurological injury using patient-derived stem cell models.
I was among the early pioneers of three-dimensional human cortical organoid technologies and contributed to development of foundational protocols for generating region-specific human brain organoids from pluripotent stem cells. My work helped establish the feasibility of modeling human brain development and disease using stem cell-derived tissues and has contributed to the widespread adoption of organoid technologies across neuroscience, regenerative medicine, and translational research.
A major focus of my laboratory is the development of increasingly sophisticated multicellular organoid and assembloid systems that incorporate diverse neuronal and glial populations to model complex human brain circuitry and disease processes. We integrate stem cell biology, organoid engineering, CRISPR-based genome editing, single-cell transcriptomics, epigenomics, high-content imaging, and computational approaches to identify disease mechanisms and therapeutic targets. These technologies have been applied to studies of hypoxic brain injury, 22q11.2 deletion syndrome, Trisomy 21 (Down Syndrome), Trisomy 18, narcolepsy, Alzheimer's and Parkinson's Disease.
